Zscaler, Ralph Lauren, Walmart, CorWave Lead Thursday Session

Major earnings reports and a significant volatility event drove activity for several key stocks on Thursday, May 21, 2026. Cloud security leader Zscaler surged 14% in premarket trading after reporting substantial upside to revenue and profit estimates for its fiscal third quarter. Luxury retailer Ralph Lauren dropped 8% following a disappointing full-year forecast, while retail giant Walmart advanced 2% on strong grocery sales. Medical device firm CorWave experienced extreme volatility, plummeting 40% after a critical clinical trial update. These moves were reported by Seeking Alpha, setting the tone for Thursday's equity session.

Context — [why these stocks are moving now]

Earnings season remains the dominant catalyst for individual stock performance, with companies facing heightened scrutiny on forward guidance amid a stable but uncertain interest rate environment. The current macroeconomic backdrop features the 10-year Treasury yield at 4.31%, providing a steady benchmark for equity valuations. The trigger for Thursday's specific moves is the conclusion of the quarterly reporting cycle for many consumer and technology firms, where guidance revisions carry more weight than historical results.

Zscaler's outperformance follows a sector-wide re-evaluation of cybersecurity spending, which has proven resilient even as other tech budgets tighten. The last significant earnings beat of this magnitude for Zscaler occurred in September 2025, when shares rallied 18% post-earnings. Conversely, Ralph Lauren's warning echoes a pattern seen in October 2025 when Tapestry Inc. cited similar macro-led weakness in discretionary luxury spending, leading to a 7% single-day decline. Walmart's resilience is consistent with its defensive characteristics during periods of consumer trade-down, a trend observed during the Q4 2024 retail squeeze.

Data — [what the numbers show]

The financial metrics underpinning Thursday's moves are concrete and significant. Zscaler reported fiscal Q3 revenue of $553 million, surpassing the consensus estimate of $535 million. The company's billings grew 27% year-over-year to $688 million, a key leading indicator for future revenue. Non-GAAP earnings per share reached $0.88, a 42% increase from the year-ago period and well above the $0.79 forecast.

Ralph Lauren provided fiscal 2027 revenue guidance projecting a decline of 1-2%, starkly contrasting with analyst expectations for 3% growth. The company's Q4 operating margin contracted 150 basis points to 9.5% due to increased promotional activity. Walmart reported a 3.8% increase in U.S. comparable sales, driven by a 4.2% jump in grocery volume, though general merchandise sales were flat. CorWave's decline erased approximately $800 million in market capitalization following the announcement that its lead device missed the primary endpoint in a 150-patient study.

Metric	Zscaler (ZS)	Ralph Lauren (RL)
Stock Move (Premarket)	+14%	-8%
Revenue vs. Estimate	+3.4% Beat	2027 Guidance Miss by ~5 pts
Key Figure	Billings: $688M	Operating Margin: 9.5%

Analysis — [what it means for markets / sectors / tickers]

Zscaler's strong results signal sustained enterprise investment in cloud security, a potential tailwind for peers like CrowdStrike and Palo Alto Networks. The 27% billings growth suggests that cybersecurity demand remains non-discretionary, insulating the sector from broader IT budget pressures. Institutional flow data indicates heavy buying in Zscaler call options, with volume exceeding the 20-day average by 300%.

The stark warning from Ralph Lauren points to mounting pressure on the discretionary retail segment. This development is a clear negative for peers such as Capri Holdings and Tapestry, which face similar consumer headwinds. The counter-argument is that Ralph Lauren's issues may be company-specific, related to its distribution channel mix rather than a broad-based luxury slump. Walmart's strength, however, confirms the ongoing trade-down effect, benefiting discounters and dollar stores while hurting mid-tier apparel brands. Investors are likely positioning long in consumer staples ETFs like XLP as a defensive maneuver against softening discretionary demand.

Outlook — [what to watch next]

The immediate catalyst for these names is market-on-close rebalancing activity, which could amplify Thursday's moves. For Zscaler, the next significant event is its analyst day scheduled for June 15, 2026, where long-term growth targets will be scrutinized. Traders will watch if the stock can hold above the $210 psychological resistance level.

Ralph Lauren investors will monitor monthly credit card data for any signs of a rebound in luxury spending ahead of the next earnings report in late July. The $135 price level represents a key support zone based on volume profile analysis. For Walmart, the next catalyst is the USDA's monthly food-at-home price index on June 25, which will inform margin expectations. CorWave's viability depends on its regulatory submission timeline to European authorities, expected by Q3 2026.

Frequently Asked Questions

Why did Zscaler stock jump so much?

Zscaler's stock surged because the company significantly exceeded analyst expectations for both revenue and earnings, while also raising its future guidance. The 27% growth in billings indicates strong future revenue visibility, which is highly valued in the software sector. This performance demonstrates that demand for its cloud security platform remains strong despite concerns about corporate IT budget cuts.

Is Ralph Lauren's weak guidance a sign of a broader retail problem?

Ralph Lauren's guidance suggests specific weakness in the high-end discretionary retail segment, but it is not necessarily indicative of the entire market. Walmart's simultaneous strength highlights a bifurcated consumer environment where budget-conscious shoppers favor essentials and discounts. The luxury sector is more exposed to economic uncertainty and reduced consumer confidence compared to value-oriented retailers.

What was the specific issue with CorWave's clinical trial?

CorWave's lead medical device, an implantable heart pump, failed to meet the primary efficacy endpoint in a pivotal clinical trial. The trial data showed no statistically significant improvement in patient outcomes compared to the control group over a six-month period. This failure delays the company's regulatory approval pathway and raises fundamental questions about the device's commercial viability, leading to the severe sell-off.

Bottom Line

Strong cybersecurity demand propelled Zscaler while luxury consumer weakness pressured Ralph Lauren, illustrating a split market reality.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.